We hypothesized that a modified, stroke-specific, version of the ACE would show similar agreement with clinician judgment and would therefore be appropriate for rapid bedside screening for MDC.
R esearch into treatments for acute strokes has dramatically increased in the last decade. Accordingly, the need for testing through randomized clinical trials has also increased. Because of the unique combination of factors that are common in acute stroke-related research, including narrow treatment windows, ethical concerns regarding research with acute stroke populations, and capacity for informed consent, stroke clinical trial enrollment levels have remained stagnant. Given the devastating consequences of acute stroke, researchers are intensifying their efforts to recruit and enroll larger sample sizes in clinical trials. 1 
Challenge
Capacity to consent to medical treatment or medical research is closely related to cognitive functioning, which is frequently impaired in stroke. 2 Medical decision-making capacity (MDC) requires the ability to understand and appreciate diagnostic, treatment, and research information and risks and ability to express a choice that is based on adequate reasoning. The treating physician is responsible for the assessment of a patient's decision-making capacity and clinically estimate their patient's ability to provide informed consent. 3 Many physicians request additional consultative assistance to assess cognitive capacity for consent from psychiatry or neuropsychology, which are considered to be the clinical gold standards 4 or they perform standardized capacity questionnaires to aid the assessment of capacity. 5, 6 One such tool, the aid-to-capacity evaluation (ACE) had 80% to 89% agreement with expert clinicians in 1 study and inter-rater reliability reported as ĸ=0.79 for medical hospitalized patients. 7, 8 The ACE has been validated and found to be one of the best available instruments to assist clinicians in making judgments on MDC. 4 It is designed to be used by trained nonclinicians and takes ≈10 minutes to perform. 4 For patients who lack capacity medical decisions are deferred to a surrogate decision maker. Surrogate decision makers in acute stroke are able to accurately predict patient treatment preferences, but are significantly less accurate in predicting patient preferences for research participation. 9 The development of a standardized validated tool to determine MDC has been instrumental in identifying patients who lack capacity in hospitalized nonstroke inpatients (see onlineonly Data Supplement). Although the ACE has been adapted for many medical conditions, it has yet to be extensively evaluated in the acute stroke population.
Presently, there is no standardized tool to evaluate decision-making capacity in stroke patients. 10 The introduction of a standardized tool to rapidly determine MDC of acute stroke patients in the emergency setting would be a significant advancement and would likely increase randomized clinical trial enrollment, especially when the clinician or study team is uncertain of the patient's cognitive status in the absence of a legal surrogate decision maker.
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intensive care units of a single tertiary-care university medical center. The study was approved by the Institutional Committee for Protection of Human Subjects.
Study Population
Patients were English speaking, ≥18-years-old, and diagnosed with either an ischemic or hemorrhagic stroke (National Institutes of Health Stroke Scale [NIHSS] score ≥1) within 10 days of symptom onset. Patients unable to hear despite assisted devices, declared legally incompetent, encephalopathic, severely lethargic or obtunded, diagnosed with dementia or severe cognitive decline, or had a current psychiatric diagnosis (schizophrenia, major depression) that would interfere with study assessment were excluded. Patients underwent 3 independent capacity assessments: ACE, psychiatrist, and neuropsychologist. Attempts were made to perform all capacity evaluations while the patient was mentally alert to reduce the variation within the patient's responses between examiners.
Measurements
To minimize discrepancy among individual examiners, every effort was undertaken to ensure that all examiners remained consistent with their technique throughout the study duration. The clinicians and the trained rater were blinded to the results of the other's assessments as well as methods used.
A research assistant (K.L. Feng) was trained on how to conduct the ACE and performed 3 practice evaluations under the supervision of the principal investigator (A.D. Barreto) and experienced research coordinators. The ACE questions were modified for stroke (see Figure  [ A] and online-only Data Supplement for further detail) by using a hypothetical scenario (Figure [B] ) followed by 7 standard questions that tested the ability to (1) understand the medical problem; (2) understand the proposed treatment; (3) understand treatment alternatives; (4) understand the option of refusing treatment; (5) appreciate the reasonably foreseeable consequences; (6) appreciate foreseeable consequences of refusing the proposed treatment; and (7) make a decision that is not based on delirium or psychiatric disturbances (ie, severe depression).
A board certified psychiatrist with extensive experience in performing hospital-based capacity evaluations assessed the patient's capability of consenting to a hypothetical scenario. This scenario concerned patient preference for new versus standard blood thinner treatments. Specific aspects of consent evaluated by the psychiatrist included (1) the ability to communicate and sustain a choice; (2) understand and describe risks, benefits, and alternatives of the proposed medication; and (3) ability to communicate his/her rationale for the choice made.
The neuropsychological examination consisted of a clinical interview and brief formal subtests chosen to evaluate comprehension and judgment. Topics ranged from simple biographical and medical information to hypothetical medical decision-making. Receptive and expressive language, attention, memory, anosognosia, and problem solving ability were assessed. This was followed by administration of the Neuropsychological Assessment Battery Judgment subtest and Complex Ideational Material and Syntactic Processing subtests from the Boston Diagnostic Aphasia Examination. 11, 12 These were sequentially chosen based on the patient's ability to complete the preceding tests (ie, presence of visual or hearing impairments, etc). Figure. A, Abbreviated version of the modified aid-to-capacity evaluation questionnaire for assessing capacity in stroke patients. B, Hypothetical scenario which is read to the patient before asking questions 2 to 7.
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Results of Pilot Testing
Thrity-one patients met study inclusion criteria and 30 agreed to participate. Sixty percent of patients were men with mild to moderate ischemic stroke (median NIHSS=6) and a mean age of 67.8 ( Table 1) . ACE evaluation required ≈5 to 7 minutes. Thirty-seven percent exhibited aphasia and neglect, whereas the remaining participants lacked these deficits. All 30 completed the ACE, but 2 patients were unable to be assessed by both clinicians. The ACE, neuropsychologist, and psychiatrist determined many patients lacked MDC: 70% (21/30), 52% (15/29), and 28% (8/29), respectively ( Table 2) . We evaluated the sensitivity and specificity as well as positive predictive value and negative predictive value of the ACE (Table 3 ). The ACE demonstrated high sensitivity: 93.8% compared with neuropsychologist and 100% compared with psychiatrist. It also had a high negative predictive value to detect intact capacity versus clinicians; misclassifying only 1 patient capable when clinicians recorded incapacity (false-negative rate of 6.2%). However, it demonstrated a 
Conclusions
The benefits of using the ACE are that unlike other instruments, the ACE uses treatment information relevant to the patient's circumstance and is therefore specific. It specifically assesses decision-making capacity using open-ended questions, and the conclusion of the ACE evaluation capacity is reliably determined. 7, 13 The ACE is the only tool that has been evaluated against a gold standard and has also performed strongly on the Journal of the American Medical Association's Rational Clinical Examination. The ACE can be used in emergency situations and can be performed in <10 minutes. 4 However, the ACE may be overly reliant on intact memory and comprehension as an aspect of the testing. Therefore, the ACE may fail to capture those patients who can make complex decisions but have initial comprehension deficits as a result of an acute stroke. The neuropsychologists considered memory, attention, and expressive and receptive language in their global assessment for MDC by listening to patient responses and using clinical expertise to interpret them. Comparatively, the psychiatrist analyzed capacity on a narrow spectrum by focusing the evaluation on a prescripted but simple specific decision at a specific moment in time.
Entering into a randomized clinical trial is a complex decision that requires patients to understand many things-the study purpose, risks, and benefits of participation, the concept of blinding, randomization, voluntarism, and withdrawal. Becauise of its high sensitivity, the ACE appears to be a useful initial screening tool to detect if a patient has complex decision-making capabilities.
There are several limitations to this study. The small sample size limits the conclusions that can be drawn and future studies should include larger sample sizes. Another limitation was the simple scenario used for the psychiatric assessment. Although every attempt was made to create a likely scenario that a patient may face poststroke, the decision-making capacity for the scenario was not complex and may not be applicable to true research studies.
In conclusion, lack of MDC is very common in mild to moderate stroke patients. The ACE can accurately identify those who can participate in stroke trials. However, failing the ACE does not, at present, adequately determine patients who cannot participate. Failing the ACE should trigger supplemental testing to adequately distinguish those who because of initial comprehension issues or stroke-specific deficits appear to lack MDC, but in fact do possess it. Additional refinement and testing of alternative, nonemergent hypothetical scenarios of the ACE for a stroke-specific population might increase its utility for determining participation capacity in randomized clinical trials. 
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STOP THE ASSESSMENT HERE [DEFINITELY INCAPABLE] IF THE PATIENT SCORES = NO
Proposed Treatment:
Say this: "For the next few questions, please answer using the scenario we are going to tell you. Here is the scenario…."
"Imagine you have suffered a second stroke that is disabling (you are paralyzed) and you are in the emergency room. The doctors offer you an optional new clotbuster medicine that gives you a good chance of being cured, but with a small risk of bleeding in the brain that could make you worse. If you don't want the clotbuster, you could receive standard treatment -aspirin, but your disability would probably stay the same. Of course, you have the right to refuse any treatment."
Question Response Score
What is the treatment that is offered?  Clotbuster for my stroke. Yes
What is the treatment that is offered? 
Aid To Capacity Evaluation (ACE)
Capacity is the ability to understand information relevant to a decision and the ability to appreciate the reasonably foreseeable consequences of a decision (or lack of a decision). The purpose of the Aid to Capacity Evaluation (ACE) is to help clinicians systematically evaluate capacity when a patient is facing a medical decision.
The developers of the ACE (i) assume no liability for any reliance by any person on the information contained herein; (ii) make no representations regarding the quality, accuracy or lawfulness related to the use of the ACE, and (iii) recommend that ACE users attend a standardized ACE training session.
The ACE was developed with the support of the physicians of Ontario through a grant from the Physicians' Services Incorporated Foundation. The ACE may be copied by any person for non-commercial use. 
Aid To Capacity Evaluation (ACE) -Training ACE TRAINING SESSION
We have developed a one hour training session to demonstrate key concepts of capacity assessment for our undergraduates and postgraduates.
The session consists of:
 An introduction, including the ethical and legal importance  A definition of capacity  A case scenario  Distribution of the ACE  An interview with a standardized patient  Scoring of the interview using the ACE  Discussion emphasizing the key process issues in capacity assessment including: establishing effective communication, ensuring adequate disclosure, and probing the person's reasons for their decision.
ACE TRAINING CASE
Mr. C. can be portrayed by a standardized patient (or the instructor).
Case History:
Mr. C. is a 70 year old widower. His wife died two years ago and he has a daughter and three sons. His relationship with his children is marked by considerable conflict. He was recently hospitalized with gangrene in his right foot and lower leg. Problems with his foot began three years ago when he had an infection in a toe in his right foot which became gangrenous. It was then that he discovered that he was diabetic. The toe was amputated. Last year, he bruised his right leg while getting into a bus. The bruise developed into gangrene which resulted in an operation 6 months ago where a portion of his foot was amputated. At that time an arterial bypass was done to decrease the likelihood that gangrene would recur. He went from the hospital to a rehabilitation centre, where he remained for five months. It was found that he had gangrene in the remainder of the foot. He was started on intravenous antibiotics with no response. A below knee operation was then suggested to him. On the morning of the operation he withdrew his consent and went home to stay with his daughter for three days. He has now been brought back to hospital by his daughter. Mr. C. has been unhappy since the death of his wife. He does not wish to burden his children, and he does not believe the operation will cure him.
Instructions:
Mr. C. will be interviewed by one of the members of your group. Use the ACE "Examples of Scoring" (see below) to help you assess Mr. C.'s capacity. Any additional information you need to fully assess Mr. C.'s capacity should be noted in the "Comments Section". 
EXAMPLES OF SCORING
